State Development & Investment Corporation (SDIC) appeared to be the VC, which was created in 1995. The fund was located in Asia if to be more exact in China. The main office of represented VC is situated in the Beijing.
The high activity for fund was in 2019. The fund is constantly included in less than 2 deals per year. This State Development & Investment Corporation (SDIC) works on 4 percentage points less the average amount of lead investments comparing to the other organizations. Considering the real fund results, this VC is 42 percentage points more often commits exit comparing to other organizations. The usual things for fund are deals in the range of 50 - 100 millions dollars. The increased amount of exits for fund were in 2018.
Among the most popular fund investment industries, there are Medical, Biotechnology. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Innovent Biologics, Video++, Realmax. The fund has no specific favorite in a number of founders of portfolio startups. When startup sums 4 or 5+ of the founder, the probability for it to get the investment is little. For fund there is a match between the location of its establishment and the land of its numerous investments - China.
The usual cause for the fund is to invest in rounds with 3-4 partakers. Despite the State Development & Investment Corporation (SDIC), startups are often financed by F-Prime Capital, Lilly Asia Ventures, Eight Roads Ventures. The meaningful sponsors for the fund in investment in the same round are YuanMing Capital, YF Capital (Yunfeng Capital), Toutoushidao Capital. In the next rounds fund is usually obtained by YuanMing Capital, Wenxuan Equity Investment Fund, UBTech Robotics.
Related Funds
Fund Name | Location |
.Invest Ukraine | - |
Center National D'Etudes Spatiales | France, Ile-de-France, Paris |
Exto Partners | Australia, New South Wales, Sydney |
Granite Oak Advisors | County Dublin, Dublin, Ireland |
Growth Circuit | California, San Francisco, United States |
Herff Jones | Indiana, Indianapolis, United States |
Indicator Ventures | New York, New York, United States |
Investcorp | Bahrain, Capital Governorate, Manama |
Kuramo Capital | New York, New York, United States |
Kyoto Chuo Shinkin Bank | Japan, Kyoto, Kyoto Prefecture |
Lovell Minnick Partners | Pennsylvania, Radnor, United States |
Moom Group | Beijing, Beijing, China |
Pareto Holdings | Florida, Miami, United States |
Reinsurance Group Of America | Chesterfield, Missouri, United States |
Ricoh Innovations | California, Menlo Park, United States |
Ruizheng Investment | - |
Sky Group | Japan, Osaka, Osaka Prefecture |
Tokyo Star Bank | Chiba, Japan, Minato |
Zlvision Tech | China, Qingdao Shi, Shandong |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Zhongke Fuhai | $123M | 03 Aug 2023 | Haidian, Beijing, China | ||
Hithium | $695M | 05 Jul 2023 | Xiamen, China | ||
Canwell Biotech | $15M | 16 Aug 2022 | Guangdong, Tianjin, China | ||
Inceptio Technology | $270M | 03 Aug 2021 | Shanghai, China | ||
Porton Biologics | $61M | 16 Apr 2021 | Suzhou, Jiangsu, China | ||
Tianfu | 01 Feb 2021 | Nanjing, Jiangsu, China | |||
$46M | 14 Jan 2021 | China, Shanghai | |||
XuanZhu Pharma | $148M | 24 Aug 2020 | Hebei, Hebei, China | ||
Allist Pharmaceuticals | $185M | 24 May 2019 | China, Shanghai |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Zhongke Fuhai | $123M | 03 Aug 2023 | Haidian, Beijing, China | ||
Hithium | $695M | 05 Jul 2023 | Xiamen, China | ||
Canwell Biotech | $15M | 16 Aug 2022 | Guangdong, Tianjin, China | ||
Inceptio Technology | $270M | 03 Aug 2021 | Shanghai, China | ||
Porton Biologics | $61M | 16 Apr 2021 | Suzhou, Jiangsu, China | ||
Tianfu | 01 Feb 2021 | Nanjing, Jiangsu, China | |||
$46M | 14 Jan 2021 | China, Shanghai | |||
XuanZhu Pharma | $148M | 24 Aug 2020 | Hebei, Hebei, China | ||
Allist Pharmaceuticals | $185M | 24 May 2019 | China, Shanghai |